Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing.
作者信息
Madden Gregory R, Cox Heather L, Poulter Melinda D, Lyman Jason A, Enfield Kyle B, Sifri Costi D
机构信息
1Division of Infectious Diseases & International Health,Department of Medicine,University of Virginia Health System,Charlottesville,Virginia.
3Clinical Microbiology Laboratory,Department of Pathology,University of Virginia Health System,Charlottesville,Virginia.
出版信息
Infect Control Hosp Epidemiol. 2019 Feb;40(2):242-244. doi: 10.1017/ice.2018.300. Epub 2018 Nov 23.
Abstract
摘要
相似文献
1
Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing.艰难梭菌检测的计算机化临床决策支持及实习生经济激励措施的成本分析
Infect Control Hosp Epidemiol. 2019 Feb;40(2):242-244. doi: 10.1017/ice.2018.300. Epub 2018 Nov 23.
2
Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.计算机临床决策支持工具和经济激励减少艰难梭菌检测和实验室鉴定事件。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):737-740. doi: 10.1017/ice.2018.53. Epub 2018 Apr 12.
3
The Impact of a Computerized Clinical Decision Support Tool on Inappropriate Clostridium difficile Testing.计算机临床决策支持工具对不适当艰难梭菌检测的影响。
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1204-1208. doi: 10.1017/ice.2017.161. Epub 2017 Aug 1.
4
Clostridium difficile--a common and costly colitis.艰难梭菌——一种常见且代价高昂的结肠炎病因。
Dis Colon Rectum. 1991 Mar;34(3):244-8. doi: 10.1007/BF02090164.
5
Use of Computerized Clinical Decision Support for Diagnostic Stewardship in Clostridioides difficile testing: an Academic Hospital Quasi-Experimental Study.计算机化临床决策支持在艰难梭菌检测诊断管理中的应用：一项学术医院的准实验研究。
J Gen Intern Med. 2019 Jan;34(1):31-32. doi: 10.1007/s11606-018-4659-4.
6
The impact of an electronic medical record nudge on reducing testing for hospital-onset infection.电子病历提示对降低医院获得性感染检测的影响。
Infect Control Hosp Epidemiol. 2020 Apr;41(4):411-417. doi: 10.1017/ice.2020.12. Epub 2020 Feb 10.
7
Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.荷兰一家三级护理中心艰难梭菌感染核糖体分型027暴发的成本分析
J Hosp Infect. 2017 Apr;95(4):421-425. doi: 10.1016/j.jhin.2016.12.019. Epub 2016 Dec 30.
8
Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.日本复发性艰难梭菌感染的医疗负担：一项回顾性数据库研究。
J Infect Chemother. 2018 Nov;24(11):892-901. doi: 10.1016/j.jiac.2018.07.020. Epub 2018 Sep 3.
9
Test stewardship, frequency and fidelity: Impact on reported hospital-onset Clostridioides difficile.检验管理、频率和忠实性：对报告的医院获得性艰难梭菌的影响。
Infect Control Hosp Epidemiol. 2019 Jun;40(6):710-712. doi: 10.1017/ice.2019.63. Epub 2019 Apr 22.
10
Reply to Wiegand et al.: proton pump inhibitor over-use and the ongoing battle to control Clostridium difficile infection in hospitals.对维甘德等人的回复：质子泵抑制剂的过度使用以及医院控制艰难梭菌感染的持续斗争。
J Hosp Infect. 2013 Jun;84(2):188. doi: 10.1016/j.jhin.2012.12.017. Epub 2013 Apr 29.
引用本文的文献
1
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics.诊断管理以改善患者结局和医疗保健相关感染 (HAI) 指标。
Infect Control Hosp Epidemiol. 2024 Apr;45(4):405-411. doi: 10.1017/ice.2023.284. Epub 2024 Jan 11.
2
The Role of Diagnostic Stewardship in Testing: Challenges and Opportunities.诊断管理在检测中的作用：挑战与机遇
Curr Infect Dis Rep. 2020 Mar;22(3). doi: 10.1007/s11908-020-0715-4. Epub 2020 Feb 17.
3
Patient Outcomes With Prevented vs Negative Tests Using a Computerized Clinical Decision Support Tool.使用计算机化临床决策支持工具时，预防检测与阴性检测的患者结局。
Open Forum Infect Dis. 2020 Mar 18;7(4):ofaa094. doi: 10.1093/ofid/ofaa094. eCollection 2020 Apr.
4
Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention.通过诊断管理综合干预减少实体器官移植受者艰难梭菌检测
Ann Transplant. 2019 May 28;24:304-311. doi: 10.12659/AOT.915168.
本文引用的文献
1
Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.计算机临床决策支持工具和经济激励减少艰难梭菌检测和实验室鉴定事件。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):737-740. doi: 10.1017/ice.2018.53. Epub 2018 Apr 12.
2
Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.美国原发性和复发性艰难梭菌感染患者的医疗资源利用和成本归因分析。
Clin Infect Dis. 2018 Apr 17;66(9):1326-1332. doi: 10.1093/cid/cix1021.
3
Diagnostic Stewardship for Healthcare-Associated Infections: Opportunities and Challenges to Safely Reduce Test Use.医疗相关感染的诊断管理：安全减少检测使用的机遇与挑战
Infect Control Hosp Epidemiol. 2018 Feb;39(2):214-218. doi: 10.1017/ice.2017.278. Epub 2018 Jan 14.
4
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.美国艰难梭菌的流行病学和经济负担：基于建模方法的估计
BMC Infect Dis. 2016 Jun 18;16:303. doi: 10.1186/s12879-016-1610-3.
5
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
6
Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肺炎克雷伯菌的肠杆菌科细菌主动监测方法的临床微生物学成本。
Infect Control Hosp Epidemiol. 2014 Apr;35(4):350-5. doi: 10.1086/675603.
7
The economic burden of Clostridium difficile.艰难梭菌的经济负担。
Clin Microbiol Infect. 2012 Mar;18(3):282-9. doi: 10.1111/j.1469-0691.2011.03571.x. Epub 2011 Jun 10.
8
Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.艰难梭菌相关疾病对成年住院患者群体的经济影响日益增加。
Infect Control Hosp Epidemiol. 2008 Sep;29(9):823-8. doi: 10.1086/588756.
9
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.艰难梭菌所致医院内腹泻的医疗费用及死亡率
Clin Infect Dis. 2002 Feb 1;34(3):346-53. doi: 10.1086/338260. Epub 2001 Dec 17.
Zotero 插件